Some studies on OBSCN gene mutations have shown that obscurin has a potential role in glioblastoma, melanoma, pancreatic cancer [70], colorectal cancer, and breast cancer [73]. This evidence concerns the gene OBSCN and familial pancreatic carcinoma.